Geneos Wealth Management Inc. Grifols Sa Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$14.07 - $17.3 $2,054 - $2,525	-146 Closed	0 $0
Q4 2020 May 19, 2021	SELL	$16.86 - $19.67 $590 - $688	-35 Reduced 19.34%	146 $2,000
Q3 2020 Sep 07, 2021	BUY	$15.4 - $20.16 $492 - $645	32 Added 21.48%	181 $2,000
Q3 2019 Sep 07, 2021	SELL	$19.85 - $22.76 $138 - $159	-7 Reduced 4.49%	149 $3,000
Q4 2018 Sep 07, 2021	BUY	$17.44 - $21.53 $174 - $215	10 Added 6.85%	156 $2,000
Q1 2017 Sep 07, 2021	SELL	N/A	-62 Reduced 29.81%	146 $2,000
Q3 2016 Sep 07, 2021	BUY	N/A	62 Added 42.47%	208 $3,000
Q1 2016 Sep 07, 2021	BUY	N/A	146	146 $2,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.